Medical News

RSS

Consumer Watchdog highlights the flaws in the proposed Senate Finance Committee health reforms

The consumer group that pioneered the most successful insurance premium regulation law in the nation, which has saved California drivers $62 billion on auto insurance rates since 1988, released a report today outlining the deep flaws in the proposed Senate Finance Committee health reforms.

9 Sep 2009

Senators return to full plate, featuring health bills

"The focus on health care as Congress reconvenes Tuesday after its monthlong recess is nearly all-consuming," The Associated Press reports. "At stake, beyond the future of health care, is an accomplishment Democrats need to convince voters they deserve to remain in power." Financial legislation, consumer protections and clean energy are also still on the table in the Senate (Abrams, 9/8).

9 Sep 2009

Laureate Pharma and Neoprobe sign manufacturing agreement

Neoprobe Corporation (OTCBB: NEOP), a diversified developer of innovative oncology surgical and diagnostic products, and Laureate Pharma, Inc., a full-service biopharmaceutical development and protein production company, today announced that they have entered into a Biopharmaceutical Development and Manufacturing Agreement.

9 Sep 2009

BioElectronics to file for FDA pre-marketing clearance of its ActiPatch Therapy product

BioElectronics Corp. (PINKSHEETS: BIEL), the maker of inexpensive, disposable drug-free anti-inflammatory devices, today announces its schedule for filing with the U.S. government's Food and Drug Administration for 510(K) pre-marketing clearance for its ActiPatch® Therapy and RecoveryRx™ products. In these applications BioElectronics will seek over-the-counter clearance of its ActiPatch Therapy product for indications for the treatment of heel and foot pain, and for pain relief relative to general musculoskeletal complaints.

9 Sep 2009

AARP members urge Congress to tackle health care reform

As Members of Congress have just returned to Washington D.C. after their summer break, Decatur AARP members are making sure they don't forget to make reforming health care a top priority. With a giant inflatable Rx bottle as backdrop, and prescription bottles filled with constituents' personal health care stories, AARP members hosted a press conference today in Decatur to deliver a strong 'message in a bottle' to Congressman Phil Hare: Health Care Reform Now.

9 Sep 2009

Free pedometers from Humana for spectators at the Utah Championship in Sandy

Have you ever wondered how many steps you take during a round of golf? You can find out for sure — and maybe even win a prize — during the Nationwide Tour’s Utah Championship, thanks to a promotion from Humana Inc. (NYSE: HUM), the official health benefits company of the PGA TOUR.

9 Sep 2009

BioLeap and GSK collaborate to discover novel medicines

BioLeap and GSK have entered into an agreement whereby BioLeap will design novel lead compounds for "difficult" drug targets. The targets (not disclosed) are ones for which conventional approaches, like high throughput screening, have failed to yield a viable chemical starting point. Typically these are in areas of high unmet medical need.

9 Sep 2009

Humana Military announces the URAC re-accreditation for its Case Management Program

Humana Military Healthcare Services, a wholly owned subsidiary of Humana Inc. (NYSE: HUM), recently received re-accreditation for its Case Management Program from URAC, a Washington, D.C.-based health care accrediting organization that establishes quality standards for the industry.

9 Sep 2009

Merck KGaA acquires Suzhou Taizhu Technology Development for € 28 million

Merck KGaA announced today that it has acquired Suzhou Taizhu Technology Development Co. Ltd. ("Taizhu"), a leading supplier of effect pigments located in Taicang near Shanghai, China. With total revenues of more than € 14 million in 2008 and 300 employees Taizhu is one of the biggest effect pigments companies in the Chinese market. The acquisition is of high strategic importance to the Merck pigments business.

9 Sep 2009

Ross: I will oppose legislation with a public plan

"In a fresh sign of divisions in the president's own party," Rep. Mike Ross, D-Ark., on Tuesday came out against including a public insurance plan in health reform legislation, the Associated Press reports. Ross said he could not support a public plan after hearing from constituents during the August recess (Werner, 9/8).

9 Sep 2009

Female insects control sperm storage to rule out genetic disorders

Scientists have found new evidence to explain how female insects can influence the father of their offspring, even after mating with up to ten males. A team from the University of Exeter has found that female crickets are able to control the amount of sperm that they store from each mate to select the best father for their young.

9 Sep 2009

NeuroMetrix to purchase $18.68 million of its common stock

NeuroMetrix, Inc., a healthcare company transforming patient care through neurotechnology, today announced that it has obtained commitments from institutional investors to purchase approximately $18.68 million of its common stock in a private placement.

9 Sep 2009

Amarillo Biosciences is midway in Phase 2 clinical study of interferon against H1N1

Amarillo Biosciences, Inc. (OTCBB: AMAR) today announced that a Phase 2 study of orally administered interferon-alpha for the prevention of influenza and winter colds has reached the midway point. The study in Perth, Australia achieved full target enrollment of 200 subjects and 98% of the subjects remain on study drug. Subjects in the study are receiving a lozenge containing interferon-alpha or a matching placebo once a day for 16 weeks.

9 Sep 2009

Lockton forms health reform advisory practice to help clients deal with changes in health system

Lockton Companies, the world's largest private insurance broker, is offering insights on the impact of health reform through its newly formed Lockton Health Reform Advisory Practice. Lockton's new team provides employers with information, advice, and practical approaches as they respond to health reform legislation and understand impact on their employees and businesses.

9 Sep 2009

Sinovac's first lot of H1N1 vaccine released by China's NICPBP

Sinovac Biotech Ltd. (NYSE Amex: SVA), a leading provider of vaccines in China, today announced that the first lot of PANFLU.1, its H1N1 vaccine, has passed the lot release process of China's National Institute for the Control of Pharmaceutical and Biological Products and obtained the Certificate for the Release of Biological Products, which means the released vaccines are ready for delivery.

9 Sep 2009

Nanoemulsion-based adjuvant increases immunity and cross protection against influenza

NanoBio Corp. announced today that data from a large ferret study indicates that its intranasal, nanoemulsion-based adjuvant elicits robust immunity and cross protection against influenza using 1/15th of the standard antigen dose, without evidence of toxicity or tolerability concerns.

9 Sep 2009

Light can be manipulated for creative and lucrative ends

The speed of light, 300 million metres per second, was long thought an immutable constant and has defined our understanding of matter and energy but recent research in the area of optics and photonics is proving that we can manipulate light to some ingenious and hugely lucrative ends.

9 Sep 2009

Health Integrated to implement behavioral health management services for Blue Cross of Idaho

Health Integrated, a leading provider of Health Management Solutions, has entered a new agreement with Blue Cross of Idaho as the health plan integrates the management of behavioral health benefits into its core operations.

9 Sep 2009

European Dynamic Annuloplasty Activation study completes patient enrollment

MiCardia (MiCardia Corporation, Irvine, California) today announced the completion of enrollment in its European “DYANA” (Dynamic Annuloplasty Activation) study, designed to support submission for CE mark of the firm’s Dynaplasty technology in Europe.

9 Sep 2009

Humana implements Application Security's DbProtect to manage critical information

Application Security, Inc., the leading provider of database security, risk and compliance solutions for the enterprise, today announced that Humana Inc. has successfully implemented DbProtect™ to manage and safeguard the highly sensitive, critical information stored on its database servers.

9 Sep 2009

Medical News

Consumer Watchdog highlights the flaws in the proposed Senate Finance Committee health reforms

Senators return to full plate, featuring health bills

Laureate Pharma and Neoprobe sign manufacturing agreement

BioElectronics to file for FDA pre-marketing clearance of its ActiPatch Therapy product

AARP members urge Congress to tackle health care reform

Free pedometers from Humana for spectators at the Utah Championship in Sandy

BioLeap and GSK collaborate to discover novel medicines

Humana Military announces the URAC re-accreditation for its Case Management Program

Merck KGaA acquires Suzhou Taizhu Technology Development for € 28 million

Ross: I will oppose legislation with a public plan

Female insects control sperm storage to rule out genetic disorders

NeuroMetrix to purchase $18.68 million of its common stock

Amarillo Biosciences is midway in Phase 2 clinical study of interferon against H1N1

Lockton forms health reform advisory practice to help clients deal with changes in health system

Sinovac's first lot of H1N1 vaccine released by China's NICPBP

Nanoemulsion-based adjuvant increases immunity and cross protection against influenza

Light can be manipulated for creative and lucrative ends

Health Integrated to implement behavioral health management services for Blue Cross of Idaho

European Dynamic Annuloplasty Activation study completes patient enrollment

Humana implements Application Security's DbProtect to manage critical information

How can microdialysis benefit drug development

Global and Local Efforts to Take Action Against Hepatitis

Addressing Important Cardiac Biology Questions with Shotgun Top-Down Proteomics

Latest News